Correspondence 0001193125-23-022966 from Solid Biosciences Inc. (SLDB)
Solid Biosciences Inc.
Date: Feb. 2, 2023 · CIK: 0001707502 · Accession: 0001193125-23-022966
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-269424
Letter
Re: Solid Biosciences Inc.
February 2, 2023
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Tim Buchmiller
Registration Statement on Form S-3
File No. 333-269424
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269424), so that it may become effective at 4:30 p.m., Eastern time, on February 6, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.
Very truly yours,
By:
Show Raw Text
CORRESP 1 filename1.htm CORRESP February 2, 2023 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Tim Buchmiller Re: Solid Biosciences Inc. Registration Statement on Form S-3 File No. 333-269424 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Solid Biosciences Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-269424), so that it may become effective at 4:30 p.m., Eastern time, on February 6, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff. Very truly yours, By: /s/ Bo Cumbo Bo Cumbo Chief Executive Officer